Eliquis vs Altace
A side-by-side look at two cardiovascular medications advertised on TV. Informational only — not medical advice.
| CA Eliquis | CA Altace | |
|---|---|---|
| Generic name | apixaban | ramipril |
| Drug class | Factor Xa Inhibitor | ACE Inhibitor |
| Treats | Blood clots, atrial fibrillation | High blood pressure, heart protection |
| Category | Cardiovascular | Cardiovascular |
| Manufacturer | Bristol-Myers Squibb/Pfizer | Sanofi |
| Year approved | 2012 | 1994 |
| FDA warning | Black box warning | Black box warning |
| Est. TV ad spend | $75M | $2M |
| Common side effects | Serious bleeding risk, Bruising, Prolonged bleeding from cuts, Blood in urine or stool | Dry cough, Dizziness, High potassium, Headache |
Frequently asked questions
Is Eliquis or Altace better?
Neither is universally "better." Eliquis (apixaban) and Altace (ramipril) are both used for cardiovascular, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Eliquis and Altace?
Eliquis is a Factor Xa Inhibitor made by Bristol-Myers Squibb/Pfizer, while Altace is a ACE Inhibitor made by Sanofi. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Eliquis has the larger estimated TV advertising budget of the two.